Rosen Law Firm, a global investor rights law firm, announces it is investigating potential claims on behalf of shareholders of OvaScience, Inc. (NASDAQ:OVAS) resulting from allegations that OvaScience may have issued materially misleading business information to the investing public.

This investigation concerns whether OvaScience made materially untrue and misleading statements and omitted material information due to OvaScience’s alleged failure to disclose that OvaScience’s AUGMENT procedure did not attain a substantial success rate of clinical pregnancies compared to rates attained without OvaScience’s AUGMENT procedure.

If you purchased shares of OvaScience, please visit the firm’s website at http://rosenlegal.com/cases-1256.html for more information. You may also contact Phillip Kim or Kevin Chan of Rosen Law Firm toll free at 866-767-3653 or via email at pkim@rosenlegal.com or kchan@rosenlegal.com.

Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm or on Twitter: https://twitter.com/rosen_firm.

Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Since 2014, Rosen Law Firm has been ranked #2 in the nation by Institutional Shareholder Services for the number of securities class action settlements annually obtained for investors.

View source version on businesswire.com: http://www.businesswire.com/news/home/20171215005506/en/

The Rosen Law Firm, P.A.
Laurence Rosen, Esq.
Phillip Kim, Esq.
Kevin Chan, Esq.
275 Madison Avenue, 34^th Floor
New York, NY 10016
Tel: 212-686-1060
Toll Free: 866-767-3653
Fax: 212-202-3827
lrosen@rosenlegal.com
pkim@rosenlegal.com
kchan@rosenlegal.com
www.rosenlegal.com

Copyright Business Wire 2017